Financial Impact of Metabolic Surgery on Prescription Diabetes Medications in Michigan

JAMA Surg. 2023 May 1;158(5):554-556. doi: 10.1001/jamasurg.2022.7749.

Authors

Oliver A Varban¹, Kristen P Hassett², Monica Yost², Arthur M Carlin¹, Amir A Ghaferi^{3

4}, Jonathan F Finks^{3

4}, Anne P Ehlers^{3

4}

Affiliations

¹ Department of Surgery, Henry Ford Health, Detroit, Michigan.
² Michigan Value Collaborative, Ann Arbor.
³ Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor.
⁴ Department of Surgery, University of Michigan, Ann Arbor.

No abstract available

Plain language summary

This study compares expenditures for diabetes medications before and after metabolic surgery among patients with diabetes in Michigan.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Bariatric Surgery*
Diabetes Mellitus*
Health Expenditures
Humans
Michigan / epidemiology
Prescriptions